John Leonard, PhD

The chief scientific officer of LocanaBio discussed preclinical research presented at ASGCT 2023.

The chief scientific officer of LocanaBio discussed preclinical data with an AAV-delivered, snRN, exon 51 skipping approach presented at ASGCT 2023.